Search research articles
Contact Us
Filters
Showing results (411-420 of 531) with videos related to
Page
of 54
Sort By:
Breast Disease
|
September 24, 2016
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer
Atilla Soran, Rohit Bhargava, Ronald Johnson, et al.
The Journal of Experimental Biology
|
February 15, 2020
Disease recovery in bats affected by white-nose syndrome
Nathan W Fuller, Liam P McGuire, Evan L Pannkuk, et al.
Journal of Drug Education
|
November 14, 2025
Substance use in Military Personnel: Associations with Combat Exposure, Moral Injury, Posttraumatic Stress Disorder and Pain
Michelle L Kelley, Jeffrey M Gabelmann, Megan Strowger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study
W P McGuire, W J Hoskins, M F Brady, et al.
Schizophrenia Research
|
August 7, 2010
Spatial working memory in individuals at high risk for psychosis: longitudinal fMRI study
P Fusar-Poli, M R Broome, P Matthiasson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study
William E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Annals of Plastic Surgery
|
June 12, 2022
The Impact of Preoperative Breast Volume on Development of Mastectomy Skin Flap Necrosis in Immediate Breast Reconstruction
Emily S Andersen, Collin Weintraub, Katherine D Reuter Muñoz, et al.
Cancer Research
|
November 1, 1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680)
C B Hendricks, L B Grochow, E K Rowinsky, et al.
Oncotarget
|
March 26, 2016
[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Laurence Booth, Jane L Roberts, Mehrad Tavallai, et al.
Cancer Research
|
June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole
A Hantel, R C Donehower, E K Rowinsky, et al.
Page
of 54
Search research articles
Search
Showing results (411-420 of 531) with videos related to
Sort By:
Page
of 54
Breast Disease
|
September 24, 2016
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer
Atilla Soran, Rohit Bhargava, Ronald Johnson, et al.
The Journal of Experimental Biology
|
February 15, 2020
Disease recovery in bats affected by white-nose syndrome
Nathan W Fuller, Liam P McGuire, Evan L Pannkuk, et al.
Journal of Drug Education
|
November 14, 2025
Substance use in Military Personnel: Associations with Combat Exposure, Moral Injury, Posttraumatic Stress Disorder and Pain
Michelle L Kelley, Jeffrey M Gabelmann, Megan Strowger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1995
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study
W P McGuire, W J Hoskins, M F Brady, et al.
Schizophrenia Research
|
August 7, 2010
Spatial working memory in individuals at high risk for psychosis: longitudinal fMRI study
P Fusar-Poli, M R Broome, P Matthiasson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study
William E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Annals of Plastic Surgery
|
June 12, 2022
The Impact of Preoperative Breast Volume on Development of Mastectomy Skin Flap Necrosis in Immediate Breast Reconstruction
Emily S Andersen, Collin Weintraub, Katherine D Reuter Muñoz, et al.
Cancer Research
|
November 1, 1991
Phase I and pharmacokinetic study of hepsulfam (NSC 329680)
C B Hendricks, L B Grochow, E K Rowinsky, et al.
Oncotarget
|
March 26, 2016
[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Laurence Booth, Jane L Roberts, Mehrad Tavallai, et al.
Cancer Research
|
June 1, 1990
Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole
A Hantel, R C Donehower, E K Rowinsky, et al.
Page
of 54